Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Refractory lupus nephritis: When, why and how to treat.

Kronbichler A, Brezina B, Gauckler P, Quintana LF, Jayne DRW.

Autoimmun Rev. 2019 Mar 4. pii: S1568-9972(19)30057-6. doi: 10.1016/j.autrev.2019.03.004. [Epub ahead of print] Review.

PMID:
30844548
2.

Estimating the epidemiology of anti-neutrophil cytoplasm antibody-associated renal vasculitis and the role of histologic chronicity in predicting renal outcomes.

Kronbichler A, Jayne DRW.

Nephrol Dial Transplant. 2019 Jan 14. doi: 10.1093/ndt/gfy402. [Epub ahead of print] No abstract available.

PMID:
30649435
3.

Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseases.

Wijetilleka S, Jayne DR, Mukhtyar C, Ala A, Bright PD, Chinoy H, Harper L, Kazmi MA, Kiani-Alikhan S, Li CK, Misbah SA, Oni L, Price-Kuehne FE, Salama AD, Workman S, Wrench D, Karim MY.

Rheumatology (Oxford). 2018 Dec 26. doi: 10.1093/rheumatology/key394. [Epub ahead of print]

PMID:
30590695
4.

Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome.

Wester Trejo MAC, Floßmann O, Westman KW, Höglund P, Hagen EC, Walsh M, Bruijn JA, Jayne DRW, Bajema IM, Berden AE.

Rheumatology (Oxford). 2019 Jan 1;58(1):103-109. doi: 10.1093/rheumatology/key260.

PMID:
30551161
5.

ANCA Renal Risk Score: is prediction of end-stage renal disease at baseline possible?

Kronbichler A, Jayne DRW.

Kidney Int. 2018 Dec;94(6):1045-1047. doi: 10.1016/j.kint.2018.10.001.

PMID:
30466561
6.

Nasal carriage of Staphylococcus pseudintermedius in patients with granulomatosis with polyangiitis.

Kronbichler A, Blane B, Holmes MA, Wagner J, Parkhill J, Peacock SJ, Jayne DRW, Harrison EM.

Rheumatology (Oxford). 2018 Nov 8. doi: 10.1093/rheumatology/key317. [Epub ahead of print] No abstract available.

7.

Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis.

Kronbichler A, Kerschbaum J, Gopaluni S, Tieu J, Alberici F, Jones RB, Smith RM, Jayne DRW.

Ann Rheum Dis. 2018 Oct;77(10):1440-1447. doi: 10.1136/annrheumdis-2017-212861. Epub 2018 Jun 27.

8.

Highlights of the 2nd EUVAS Vasculitis Course.

Emmi G, Salvarani C, Prisco D, Jayne DRW, Vaglio A.

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):3-11. Epub 2018 May 18. No abstract available.

PMID:
29799392
9.

Comment on: Rituximab therapy for Takayasu arteritis: a seven patients experience and a review of the literature.

Nakagomi D, Kronbichler A, Witte T, Mohammad AJ, Jayne DRW.

Rheumatology (Oxford). 2018 Jan 29. doi: 10.1093/rheumatology/kex493. [Epub ahead of print] No abstract available.

PMID:
29385531
10.

Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data.

de Joode AAE, Sanders JSF, Puéchal X, Guillevin LP, Hiemstra TF, Flossmann O, Rasmussen N, Westman K, Jayne DR, Stegeman CA.

Rheumatology (Oxford). 2017 Nov 1;56(11):1894-1901. doi: 10.1093/rheumatology/kex281.

PMID:
28977502
11.

Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts.

Yates M, Watts R, Bajema I, Cid M, Crestani B, Hauser T, Hellmich B, Holle J, Laudien M, Little MA, Luqmani RA, Mahr A, Merkel P, Mills J, Mooney J, Segelmark M, Tesar V, Westman KWA, Vaglio A, Yalçındağ N, Jayne DR, Mukhtyar C.

RMD Open. 2017 Jun 15;3(1):e000449. doi: 10.1136/rmdopen-2017-000449. eCollection 2017.

12.

Severe Infection in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Mohammad AJ, Segelmark M, Smith R, Englund M, Nilsson JÅ, Westman K, Merkel PA, Jayne DRW.

J Rheumatol. 2017 Oct;44(10):1468-1475. doi: 10.3899/jrheum.160909. Epub 2017 Aug 1.

PMID:
28765251
13.

Pulmonary Involvement in Antineutrophil Cytoplasmic Antibodies (ANCA)-associated Vasculitis: The Influence of ANCA Subtype.

Mohammad AJ, Mortensen KH, Babar J, Smith R, Jones RB, Nakagomi D, Sivasothy P, Jayne DRW.

J Rheumatol. 2017 Oct;44(10):1458-1467. doi: 10.3899/jrheum.161224. Epub 2017 Aug 1.

PMID:
28765242
14.

Rituximab for immunologic renal disease: What the nephrologist needs to know.

Kronbichler A, Windpessl M, Pieringer H, Jayne DRW.

Autoimmun Rev. 2017 Jun;16(6):633-643. doi: 10.1016/j.autrev.2017.04.007. Epub 2017 Apr 13. Review.

PMID:
28414152
15.

Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis.

Jayne DRW, Bruchfeld AN, Harper L, Schaier M, Venning MC, Hamilton P, Burst V, Grundmann F, Jadoul M, Szombati I, Tesař V, Segelmark M, Potarca A, Schall TJ, Bekker P; CLEAR Study Group.

J Am Soc Nephrol. 2017 Sep;28(9):2756-2767. doi: 10.1681/ASN.2016111179. Epub 2017 Apr 11.

16.

Chronic nasal Staphylococcus aureus carriage identifies a subset of newly diagnosed granulomatosis with polyangiitis patients with high relapse rate.

Salmela A, Rasmussen N, Tervaert JWC, Jayne DRW, Ekstrand A; European Vasculitis Study Group.

Rheumatology (Oxford). 2017 Jun 1;56(6):965-972. doi: 10.1093/rheumatology/kex001.

PMID:
28339745
17.

Complement in ANCA-associated vasculitis: mechanisms and implications for management.

Chen M, Jayne DRW, Zhao MH.

Nat Rev Nephrol. 2017 Jun;13(6):359-367. doi: 10.1038/nrneph.2017.37. Epub 2017 Mar 20. Review.

PMID:
28316335
18.

Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial.

Gopaluni S, Smith RM, Lewin M, McAlear CA, Mynard K, Jones RB, Specks U, Merkel PA, Jayne DR; RITAZAREM Investigators.

Trials. 2017 Mar 7;18(1):112. doi: 10.1186/s13063-017-1857-z.

19.

Response to: 'Renal biopsies should be performed whenever treatment strategies depend on renal involvement' by Chemouny et al.

Yates M, Jayne DR, Mukhtyar C.

Ann Rheum Dis. 2017 Aug;76(8):e28. doi: 10.1136/annrheumdis-2016-210962. Epub 2017 Jan 25. No abstract available.

PMID:
28122763
20.

ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse.

Göçeroğlu A, Berden AE, Fiocco M, Floßmann O, Westman KW, Ferrario F, Gaskin G, Pusey CD, Hagen EC, Noël LH, Rasmussen N, Waldherr R, Walsh M, Bruijn JA, Jayne DR, Bajema IM; European Vasculitis Society (EUVAS).

PLoS One. 2016 Dec 14;11(12):e0165402. doi: 10.1371/journal.pone.0165402. eCollection 2016.

21.

Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis.

van Daalen EE, Rizzo R, Kronbichler A, Wolterbeek R, Bruijn JA, Jayne DR, Bajema IM, Rahmattulla C.

Ann Rheum Dis. 2017 Jun;76(6):1064-1069. doi: 10.1136/annrheumdis-2016-209925. Epub 2016 Nov 29.

PMID:
27899372
22.

Comparison of the Phenotype and Outcome of Granulomatosis with Polyangiitis Between UK and Japanese Cohorts.

Furuta S, Chaudhry AN, Arimura Y, Dobashi H, Fujimoto S, Homma S, Rasmussen N, Jayne DR.

J Rheumatol. 2017 Feb;44(2):216-222. doi: 10.3899/jrheum.160005. Epub 2016 Nov 1.

PMID:
27803133
23.

Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis.

Alberici F, Smith RM, Fonseca M, Willcocks LC, Jones RB, Holle JU, Wieczorek S, Neumann T, Martorana D, Gregorini G, Sinico RA, Bruchfeld A, Gunnarsson I, Ohlsson S, Baslund B, Tesar V, Hruskova Z, Cid MC, Vaglio A, Lyons PA, Smith KGC, Jayne DRW.

J Allergy Clin Immunol. 2017 May;139(5):1684-1687.e10. doi: 10.1016/j.jaci.2016.08.051. Epub 2016 Oct 22. No abstract available.

PMID:
27780742
24.

Opponent's comments.

Fernandez Nieto M, Jayne DR.

Nephrol Dial Transplant. 2016 Oct;31(10):1566-7. doi: 10.1093/ndt/gfw289a. No abstract available.

PMID:
27683730
25.

Con: The use of calcineurin inhibitors in the treatment of lupus nephritis.

Fernandez Nieto M, Jayne DR.

Nephrol Dial Transplant. 2016 Oct;31(10):1567-71. doi: 10.1093/ndt/gfw291. Epub 2016 Sep 1.

PMID:
27591328
26.

Successful outcome using bortezomib in adult refractory IgA vasculitis: a case report.

Van de Perre E, Smith RM, Bardsley V, Crawley C, Willcocks LC, Jayne DR.

Rheumatology (Oxford). 2016 Nov;55(11):2089-2091. Epub 2016 Jul 24. No abstract available.

PMID:
27453187
27.

An unusual finding in a 57-year-old woman with new onset hypertension and a diastolic murmur.

Tarkin JM, Rudd JH, Jayne DR, Rusk RA, Gopalan D.

Heart. 2016 Nov 1;102(21):1762. doi: 10.1136/heartjnl-2016-309661. Epub 2016 Jul 13.

28.

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.

Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, Hellmich B, Holle JU, Laudien M, Little MA, Luqmani RA, Mahr A, Merkel PA, Mills J, Mooney J, Segelmark M, Tesar V, Westman K, Vaglio A, Yalçındağ N, Jayne DR, Mukhtyar C.

Ann Rheum Dis. 2016 Sep;75(9):1583-94. doi: 10.1136/annrheumdis-2016-209133. Epub 2016 Jun 23.

29.

Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases.

Flint SM, Jovanovic V, Teo BW, Mak A, Thumboo J, McKinney EF, Lee JC, MacAry P, Kemeny DM, Jayne DR, Fong KY, Lyons PA, Smith KG.

RMD Open. 2016 May 16;2(1):e000183. doi: 10.1136/rmdopen-2015-000183. eCollection 2016.

30.

Hurdles to the introduction of new therapies for immune-mediated kidney diseases.

Anders HJ, Jayne DR, Rovin BH.

Nat Rev Nephrol. 2016 Apr;12(4):205-16. doi: 10.1038/nrneph.2015.206. Epub 2016 Jan 25. Review.

PMID:
26804020
31.

Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review.

Kronbichler A, Brezina B, Quintana LF, Jayne DR.

Autoimmun Rev. 2016 Jan;15(1):38-49. doi: 10.1016/j.autrev.2015.08.010. Epub 2015 Aug 28. Review.

PMID:
26318215
32.

Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience.

Mohammad AJ, Smith RM, Chow YW, Chaudhry AN, Jayne DR.

J Rheumatol. 2015 Oct;42(10):1906-13. doi: 10.3899/jrheum.141344. Epub 2015 Aug 15.

PMID:
26276966
33.

T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection.

McKinney EF, Lee JC, Jayne DR, Lyons PA, Smith KG.

Nature. 2015 Jul 30;523(7562):612-6. doi: 10.1038/nature14468. Epub 2015 Jun 29.

34.

Opponent's comments.

Kronbichler A, Jayne DR.

Nephrol Dial Transplant. 2015 Jul;30(7):1087-8. doi: 10.1093/ndt/gfv217a. No abstract available.

PMID:
26109683
35.

Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.

Shah S, Hruskova Z, Segelmark M, Morgan MD, Hogan J, Lee SK, Dale J, Harper L, Tesar V, Jayne DR, Geetha D.

Am J Nephrol. 2015;41(4-5):296-301. doi: 10.1159/000431336. Epub 2015 Jun 2.

36.

Con: Should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab?

Kronbichler A, Jayne DR.

Nephrol Dial Transplant. 2015 Jul;30(7):1075-81. doi: 10.1093/ndt/gfv216. Epub 2015 May 21.

PMID:
25999374
37.

Rituximab for treatment of severe renal disease in ANCA associated vasculitis.

Geetha D, Hruskova Z, Segelmark M, Hogan J, Morgan MD, Cavero T, Eriksson P, Seo P, Manno RL, Dale J, Harper L, Tesar V, Jayne DR.

J Nephrol. 2016 Apr;29(2):195-201. doi: 10.1007/s40620-015-0208-y. Epub 2015 May 19.

PMID:
25986390
38.

Lupus nephritis management guidelines compared.

Wilhelmus S, Bajema IM, Bertsias GK, Boumpas DT, Gordon C, Lightstone L, Tesar V, Jayne DR.

Nephrol Dial Transplant. 2016 Jun;31(6):904-13. doi: 10.1093/ndt/gfv102. Epub 2015 Apr 28. Review.

39.

Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease.

Jones RB, Walsh M, Chaudhry AN, Smith KG, Jayne DR.

Clin Kidney J. 2014 Dec;7(6):562-8. doi: 10.1093/ckj/sfu096. Epub 2014 Sep 16.

40.

A historical essay on detection of anti-neutrophil cytoplasmic antibodies.

Rasmussen N, Wiik A, Jayne DR.

Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i8-13. doi: 10.1093/ndt/gfv070. Review.

PMID:
25805749
41.

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.

Jones RB, Furuta S, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh M, Westman K, Jayne DR; European Vasculitis Society (EUVAS).

Ann Rheum Dis. 2015 Jun;74(6):1178-82. doi: 10.1136/annrheumdis-2014-206404. Epub 2015 Mar 4.

PMID:
25739829
42.

Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis.

Kronbichler A, Jayne DR, Mayer G.

Eur J Clin Invest. 2015 Mar;45(3):346-68. doi: 10.1111/eci.12410. Review.

PMID:
25627555
43.

Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: a case series.

Roberts DM, Jones RB, Smith RM, Alberici F, Kumaratne DS, Burns S, Jayne DR.

J Autoimmun. 2015 Feb;57:24-9. doi: 10.1016/j.jaut.2014.11.004. Epub 2015 Jan 10.

PMID:
25586449
44.

Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease.

Roberts DM, Jones RB, Smith RM, Alberici F, Kumaratne DS, Burns S, Jayne DR.

J Autoimmun. 2015 Feb;57:60-5. doi: 10.1016/j.jaut.2014.11.009. Epub 2014 Dec 31.

PMID:
25556904
45.

Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis.

Alberici F, Smith RM, Jones RB, Roberts DM, Willcocks LC, Chaudhry A, Smith KG, Jayne DR.

Rheumatology (Oxford). 2015 Jul;54(7):1153-60. doi: 10.1093/rheumatology/keu452. Epub 2014 Dec 3.

46.

Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

Mohammad AJ, Hot A, Arndt F, Moosig F, Guerry MJ, Amudala N, Smith R, Sivasothy P, Guillevin L, Merkel PA, Jayne DR.

Ann Rheum Dis. 2016 Feb;75(2):396-401. doi: 10.1136/annrheumdis-2014-206095. Epub 2014 Dec 2.

PMID:
25467294
47.

Renal function and ear, nose, throat involvement in anti-neutrophil cytoplasmic antibody-associated vasculitis: prospective data from the European Vasculitis Society clinical trials.

Rahmattulla C, de Lind van Wijngaarden RA, Berden AE, Hauer HA, Floßmann O, Jayne DR, Gaskin G, Rasmussen N, Noël LH, Ferrario F, Waldherr R, Wolterbeek R, Göçeroğlu A, Pusey CD, Hagen EC, Bruijn JA, Bajema IM; European Vasculitis Study Group (EUVAS).

Rheumatology (Oxford). 2015 May;54(5):899-907. doi: 10.1093/rheumatology/keu357. Epub 2014 Oct 22.

PMID:
25342376
48.

Human T-follicular helper and T-follicular regulatory cell maintenance is independent of germinal centers.

Wallin EF, Jolly EC, Suchánek O, Bradley JA, Espéli M, Jayne DR, Linterman MA, Smith KG.

Blood. 2014 Oct 23;124(17):2666-74. doi: 10.1182/blood-2014-07-585976. Epub 2014 Sep 15.

49.

Long-term follow-up of cyclophosphamide compared with azathioprine for initial maintenance therapy in ANCA-associated vasculitis.

Walsh M, Faurschou M, Berden A, Flossmann O, Bajema I, Hoglund P, Smith R, Szpirt W, Westman K, Pusey CD, Jayne DR; European Vasculitis Study Group.

Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1571-6. doi: 10.2215/CJN.00100114. Epub 2014 Jun 26.

50.

The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease.

Marco H, Smith RM, Jones RB, Guerry MJ, Catapano F, Burns S, Chaudhry AN, Smith KG, Jayne DR.

BMC Musculoskelet Disord. 2014 May 25;15:178. doi: 10.1186/1471-2474-15-178.

Supplemental Content

Loading ...
Support Center